Results 11 to 20 of about 10,004,929 (375)
Expert Consensus on Tumor Mutational Burden for Immunotherapy in Lung Cancer
Chinese Journal of Lung Cancer, 2021 Lung cancer is one of the malignant tumors with the highest morbidity and mortality in the world. Immune checkpoint inhibitors (ICIs), including programmed cell death 1 (PD-1) antibody, programmed cell death ligand 1 (PD-L1) antibody, and cytotoxic T ...
Chinese Society of Clinical Oncology, Expert Committee on Tumor Vascular-targeted Therapy +1 more
doaj +1 more source
An Overview of Clinical Oncology and Impact on Oral Health
Frontiers in Oral Health, 2022 As the incidence of cancer continues to increase, so too will the use of various forms of cancer therapeutics and their associated oral and dental complications.
Jack A. Harris +5 more
doaj +1 more source
Chinese Journal of Lung Cancer, 2023 With the development of precision diagnosis and treatment for non-small cell lung cancer (NSCLC), the epidermal growth factor receptor (EGFR) exon 20 insertion (ex20ins) mutations, as a rare subset of EGFR mutaions, have gradually attracted attention ...
Chinese Society of Clinical Oncology (CSCO) Non-small Cell Lung Cancer Committee
doaj +1 more source
Cancer Communications, 2021 There exist differences in the epidemiological characteristics, clinicopathological features, tumor biological characteristics, treatment patterns, and drug selections between gastric cancer patients from the Eastern and Western countries.
Fenghua Wang +33 more
semanticscholar +1 more source
Cancer Communications, 2021 Nasopharyngeal carcinoma (NPC) is a malignant epithelial tumor originating in the nasopharynx and has a high incidence in Southeast Asia and North Africa.
L. Tang +39 more
semanticscholar +1 more source
Metabolomics in cancer research and emerging applications in clinical oncology
Ca, 2021 Cancer has myriad effects on metabolism that include both rewiring of intracellular metabolism to enable cancer cells to proliferate inappropriately and adapt to the tumor microenvironment, and changes in normal tissue metabolism.
D. R. Schmidt +5 more
semanticscholar +1 more source
Archives of Pathology & Laboratory Medicine, 2018 PURPOSE.— To update key recommendations of the American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) human epidermal growth factor receptor 2 (HER2) testing in breast cancer guideline.
A. Wolff +16 more
semanticscholar +2 more sources
The Exercise Oncology Knowledge Mobilization Initiative: An International Modified Delphi Study
Frontiers in Oncology, 2021 IntroductionExercise is vital to health and well-being after a cancer diagnosis yet is poorly integrated in cancer care. Knowledge mobilization (KM) is essential to enhance exercise opportunities.
Scott C. Adams +21 more
doaj +1 more source
Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.
The Journal of the National Comprehensive Cancer Network, 2023 Adenocarcinoma of the endometrium (also known as endometrial cancer, or more broadly as uterine cancer or carcinoma of the uterine corpus) is the most common malignancy of the female genital tract in the United States.
N. Abu-Rustum +36 more
semanticscholar +1 more source
Journal of Clinical Oncology, 2013 PURPOSE To update the American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) guideline recommendations for human epidermal growth factor receptor 2 (HER2) testing in breast cancer to improve the accuracy of HER2 testing and ...
Antonio C. Wolff +19 more
semanticscholar +1 more source